Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia

ClinicalTrials.gov ID: NCT00453388

Public ClinicalTrials.gov record NCT00453388. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Nonmyeloablative Hematopoietic Cell Transplantation for Patients With Fanconi Anemia Using Alternative Marrow Donors: A Phase II Dose-Finding Study

Study identification

NCT ID
NCT00453388
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Fred Hutchinson Cancer Center
Other
Enrollment
6 participants

Conditions and interventions

Interventions

  • Allogeneic Bone Marrow Transplantation Procedure
  • Cyclophosphamide Drug
  • Cyclosporine Drug
  • Fludarabine Phosphate Drug
  • Laboratory Biomarker Analysis Other
  • Mycophenolate Mofetil Drug
  • Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation Procedure
  • Total-Body Irradiation Radiation

Procedure · Drug · Other + 1 more

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2007
Primary completion
May 31, 2013
Completion
May 31, 2013
Last update posted
Jan 28, 2020

2007 – 2013

United States locations

U.S. sites
4
U.S. states
4
U.S. cities
4
Facility City State ZIP Site status
Children's Hospital and Research Center at Oakland Oakland California 94609-1809
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle Washington 98109
Children's Hospital of Wisconsin Milwaukee Wisconsin 53201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00453388, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00453388 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →